InvestorsHub Logo
Followers 41
Posts 3686
Boards Moderated 0
Alias Born 03/28/2013

Re: None

Tuesday, 02/13/2024 6:02:41 PM

Tuesday, February 13, 2024 6:02:41 PM

Post# of 409985
If you want to read a great explanation of why Purdue lost to Accord. This does a great job. I don't see Purdue prevailing upon any appeal


https://www.jdsupra.com/legalnews/purdue-pharma-l-p-v-accord-healthcare-9240156/


https://www.jdsupra.com/legalnews/purdue-pharma-l-p-v-accord-healthcare-7316338/

On commercial success, the court found that reformulated OxyContin’s sales are the product of Purdue’s existing monopoly, not the claimed limitations. The court then dismissed Purdue’s evidence of industry skepticism, concluding that the inventor “does not serve as a stand-in for a POSA, or for the industry.” Finally, the court found that Purdue did not prove failure of others.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News